These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1825387)

  • 1. Selective inhibition of platelet-derived thromboxane A2 in patients with lupus anticoagulant using low doses aspirin as assessed by enzyme immunoassay.
    Lellouche F; Falcon C; Carreras L; Maclouf J
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():611-4. PubMed ID: 1825387
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis.
    Hasselaar P; Derksen RH; Blokzijl L; de Groot PG
    Thromb Haemost; 1988 Feb; 59(1):80-5. PubMed ID: 3129812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin.
    Pulcinelli FM; Riondino S; Celestini A; Pignatelli P; Trifirò E; Di Renzo L; Violi F
    J Thromb Haemost; 2005 Dec; 3(12):2784-9. PubMed ID: 16359516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of prostacyclin and platelet thromboxane A2 by aspirin.
    N Engl J Med; 1981 May; 304(19):1173-5. PubMed ID: 7012620
    [No Abstract]   [Full Text] [Related]  

  • 5. Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies.
    Rauch J; Meng QH; Tannenbaum H
    J Immunol; 1987 Oct; 139(8):2598-604. PubMed ID: 3116088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of aspirin to impair bovine platelet function.
    Gentry PA; Tremblay RR; Ross ML
    Am J Vet Res; 1989 Jun; 50(6):919-22. PubMed ID: 2764343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin resistance: what, why and when?
    Shantsila E; Watson T; Lip GY
    Thromb Res; 2007; 119(5):551-4. PubMed ID: 17010411
    [No Abstract]   [Full Text] [Related]  

  • 8. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutional thrombocytopathy with subnormal response to thromboxane A2.
    Samama M; Lecrubier C; Conard J; Hotchen M; Breton-Gorius J; Vargaftig B; Chignard M; Lagarde M; Dechavanne M
    Br J Haematol; 1981 Jun; 48(2):293-303. PubMed ID: 7195274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis and pharmacological modulation of thromboxane in humans.
    Patrono C
    Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of differential inhibition of thromboxane A2 and prostacyclin by low and high dose aspirin in coronary artery disease.
    Klein RC; Beckman J; Peake G
    Can J Cardiol; 1987 Sep; 3(6):288-92. PubMed ID: 3322532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin.
    Evangelista V; Manarini S; Di Santo A; Capone ML; Ricciotti E; Di Francesco L; Tacconelli S; Sacchetti A; D'Angelo S; Scilimati A; Sciulli MG; Patrignani P
    Circ Res; 2006 Mar; 98(5):593-5. PubMed ID: 16484611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the inhibitory effects of aspirin and ticlopidine on platelet aggregation and Ca2+ mobilization in rat platelets.
    Morikawa M; Kojima T; Inoue M; Tsuboi M
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):275-8. PubMed ID: 3024274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
    Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
    Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo".
    Landolfi R; De Candia E; Rocca B; Ciabattoni G; Antinori A; Masetti R; Patrono C
    Thromb Haemost; 1994 Dec; 72(6):942-6. PubMed ID: 7740468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
    Mazurov AB; Leĭtin VL; Repin VS
    Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose-aspirin: treatment of the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia.
    Saleh AA; Bottoms SF; Mammen EF
    Am J Perinatol; 1992 Jul; 9(4):311-3. PubMed ID: 1627229
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
    Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More on aspirin resistance: position paper of the Working Group on Aspirin Resistance. Proposal for a Laboratory Test Guiding Algorithm.
    Pulcinelli FM; Riondino S
    J Thromb Haemost; 2006 Feb; 4(2):485-7. PubMed ID: 16420589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.